ITCI

Intra-Cellular Therapies Inc.
ITCI

Overview Fund Activity
Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

127 hedge funds and large institutions have $418M invested in Intra-Cellular Therapies Inc. in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 42 increasing their positions, 46 reducing their positions, and 18 closing their positions.

Holders
127
Holders Change
-4
Holders Change %
-3.05%
% of All Funds
2.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
42
Reduced
46
Closed
18
Calls
$49.3M
Puts
$11.8M
Net Calls
+$37.6M
Net Calls Change
+$13.9M

Top Buyers

1
SC
1
Samlyn Capital
New York
$14.4M
2
Millennium Management
2
Millennium Management
New York
$10.5M
3
GAI
3
General American Investors
New York
$3.42M
4
Citadel Advisors
4
Citadel Advisors
Florida
$11.9M
5
Two Sigma Investments
5
Two Sigma Investments
New York
$2.19M

Top Sellers

1
Balyasny Asset Management
1
Balyasny Asset Management
Illinois
$0
2
DFO
2
Duquesne Family Office
New York
$0
3
Bank of America
3
Bank of America
North Carolina
$3.19M
4
CCP
4
Clough Capital Partners
Massachusetts
$1.53M
5
RSCM
5
Rock Springs Capital Management
Maryland
$0
Name Market Value Shares Shares
Change 		Shares
Change %
DAM
151
DLD Asset Management
New York
– – – –
PHK
152
Point72 Hong Kong
Hong Kong
$0 19 +19 New
3 4 5 6
7